Eli Lilly and Company - Company Profile and SWOT Analysis
SummaryEli Lilly and Company - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Eli Lilly and Company (Eli Lilly or 'the company') is a pharmaceutical company that discovers, develops, manufactures, and sells pharmaceutical products. The company offers pharmaceutical products in the therapeutic areas of neuroscience, endocrinology, oncology, cardiovascular, and immunology. It offers its products under brands including Baqsimi, Basaglar, Cymbalta, Olumiant,Verzenio, cialis and Erbitux. The company distributes its products through wholesalers, on-line health care channels and sales representatives. Eli Lilly offers its products to pharmacies, hospitals, physicians, and other healthcare professionals. It has a business presence in the US, Japan, Europe, and other countries. The company is headquartered in Indianapolis, Indiana, the US.
Scope
Eli Lilly and Company - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Eli Lilly and Company (Eli Lilly or 'the company') is a pharmaceutical company that discovers, develops, manufactures, and sells pharmaceutical products. The company offers pharmaceutical products in the therapeutic areas of neuroscience, endocrinology, oncology, cardiovascular, and immunology. It offers its products under brands including Baqsimi, Basaglar, Cymbalta, Olumiant,Verzenio, cialis and Erbitux. The company distributes its products through wholesalers, on-line health care channels and sales representatives. Eli Lilly offers its products to pharmacies, hospitals, physicians, and other healthcare professionals. It has a business presence in the US, Japan, Europe, and other countries. The company is headquartered in Indianapolis, Indiana, the US.
Reasons To Buy
- Detailed information on Eli Lilly and Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Eli Lilly and Company in the form of a SWOT analysis
- An in-depth view of the business model of Eli Lilly and Company including a breakdown and examination of key business segments
- Intelligence on Eli Lilly and Company's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Eli Lilly and Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.